Targeting efficiency and biodistribution of zoledronate conjugated docetaxel loaded pegylated pbca nanoparticles for bone metastasis

Advanced Functional Materials

Volumn 22, Issue 19, 2012, Pages 4101-4114

  Chaudhari, Kiran R ^a,b,c   Kumar, Abhinesh ^a   Khandelwal, Vinoth Kumar Megraj ^b   Mishra, Anil K ^c,d   Monkkonen, Jukka ^b   Murthy, Rayasa S Ramachandra ^e  

^a M S UNIVERSITY OF BARODA   (India)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

^d Consorzio Mario Negri Sud ^*  (Italy)

^e ISF COLLEGE OF PHARMACY   (India)

Author keywords

bisphosphonates; bone targeting; docetaxel; polybutyl cyanoacrylate (PBCA) nanoparticles; zoledronic acid

Indexed keywords

AFTER-TREATMENT; BIODISTRIBUTIONS; BISPHOSPHONATES; BONE METASTASIS; CAVEOLAE; CELL LINES; CELL-CYCLE ARREST; CELLULAR UPTAKE; CHARACTERIZATION STUDIES; CLATHRINS; CONTROL GROUPS; CYANOACRYLATES; CYTOPLASMIC PROTEINS; CYTOTOXIC; CYTOTOXIC EFFECTS; DOCETAXEL; GENISTEIN; MCF-7 CELLS; METASTATIC TUMORS; MOLECULAR BASIS; PROGRAMMED CELL DEATHS; SYNERGISTIC EFFECT; TARGETED DELIVERY; TIME POINTS; TUMOR LOCALIZATION; UPTAKE ROUTE; ZOLEDRONIC ACID;

ADHESIVES; ANIONIC POLYMERIZATION; CELL CULTURE; CELL DEATH; COMPENSATION (PERSONNEL); CONFOCAL MICROSCOPY; CYTOTOXICITY; FLAVONOIDS; MOLECULAR BIOLOGY; NANOPARTICLES; PATHOLOGY; POLYETHYLENE GLYCOLS; TUMORS;

BONE;

EID: 84867037582     PISSN: 1616301X     EISSN: 16163028     Source Type: Journal    
DOI: 10.1002/adfm.201102357     Document Type: Article

References (55)

1. J. M. Chirgwin, T. A. Guise, Sci. Med. 2003, 9, 140.
2. G. R. Mundy, Cancer 1997, 80, 1546.
3. E. C. Woodhouse, R. F. Chuaqui, L. A. Liotta, Cancer 1997, 80, 1529.
4. A. A. El-Mabhouha, C. A. Angelov, R. Cavell, J. R. Mercer, Nucl. Med. Biol. 2006, 33, 715.
5. H. Fleisch, Endocr. Rev. 1998, 19, 80.
6. X. M. Liu, A. T. Wiswall, J. E. Rutledge, M. P. Akhter, D. M. Cullen, R. A. Reinhardt, D. Wang, Biomaterials 2008, 29, 1686.
7. V. Hengst, C. Oussoren, T. Kissel, G. Storm, Int. J. Pharm. 2007, 331, 224.
8. H. Bentz, D. Rosen, European Patent, 1992, 0512844.
9. M. J. Robert, A. Kozlowski, US Patent, 2002, 6436386.
10. T. Chen, J. Berenson, R. Vescio, R. Swift, A. Gilchick, S. Goodin, P. LoRusso, P. Ma, C. Ravera, F. Deckert, H. Schran, J. Seaman, A. Skerjanec, J. Clin. Pharmacol. 2002, 42, 1228.
11. S. Alila, A. M. Ferraria, A. M. Botelho do Rego, S. Boufi, Carbohydr. Polym. 2009, 77, 553.
12. K. R. Chaudhari, M. Ukawala, A. S. Manjappa, A. Kumar, P. K. Mundada, A. K. Mishra, R. Mathur, J. Mönkkönen, R. S. R. Murthy, Pharm. Res. 2012, 29, 53.
13. O. Peyruchaud, B. Winding, I. Pecheur, C. M. Serre, P. Delmas, P. Clezardin, J. Bone Miner. Res. 2001, 16, 2027.
14. S. K. Sahoo, V. Labhasetwar, Mol. Pharmacol. 2005, 2, 373.
15. T. K. Jain, J. Richey, M. Strand, D. L. Leslie-Pelecky, C. A. Flask, V. Labhasetwar, Biomaterials 2008, 29, 4012.
16. J. Panyam, V. Labhasetwar, Pharm. Res. 2003, 20, 212.
17. F. Vega, L. J. Medeiros, V. Leventaki, C. Atwell, J. H. Cho-Vega, L. Tian, F. X. Claret, G. Z. Rassidakis, Cancer Res. 2006, 66, 6589.
18. M. Jauhiainen, H. Mönkkönen, J. Räikkönen, J. Mönkkönen, S. Auriola, J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2009, 877, 2967.
19. H. Monkkonen, P. Moilanen, J. Monkkonen, J. C. Frith, M. J. Rogers, S. Auriola, J. Chromatogr., B: Biomed. Sci. Appl. 2000, 738, 395.
20. L. H. Reddy, R. K. Sharma, K. Chuttani, A. K. Mishra, R. R. Murthy, AAPS J. 2004, 6, e23.
21. N. Arulsudar, N. Subramanian, P. Mishra, K. Chuttani, R. K. Sharma, R. S. Murthy, AAPS J. 2004, 6, 45.
22. G. B. Saha, Fundamentals of Nuclear Pharmacy, 5th ed., Springer-Verlag, New York 2005.
23. A. K. Babbar, A. K. Singh, H. C. Goel, U. P. S. Chauhan, R. K. Sharma, Nucl. Med. Biol. 2000, 27, 419.
24. I. A. Khalil, K. Kogure, H. Akita, H. Harashima, Pharmacol. Rev. 2006, 58, 32.
25. S. D. Conner, S. L. Schmid, Nature 2003, 422, 37.
26. L. Johannes, C. Lamaze, Traffic 2002, 3, 443.
27. K. R. Chaudhari, A. Kumar, V. K. M. Khandelwal, M. Ukawala, A. S. Manjappa, A. K. Mishra, J. Monkkonen, R. S. R. Murthy, J. Controlled Release 2011, 158, 470.
28. M. D. Chavanpatil, J. Panyam, J. Nanosci. Nanotechnol. 2006, 6, 2651.
29. H. Y. Nam, S. M. Kwon, H. Chung, S. Y. Lee, S. H. Kwom, H. Jeon, Y. Kim, J. H. Park, J. Kim, S. Her, Y. K. Oh, I. C. Kwon, K. Kim, S. Y. Jeong, J. Controlled Release 2009, 135, 259.
30. M. P. Desai, V. Labhasetwar, G. L. Amidon, R. J. Levy, Pharm. Res. 1996, 13, 1838.
31. Y. H. Kim, S. H. Gihm, C. R. Park, K. Y. Lee, T. W. Kim, I. C. Kwon, H. Chung, S. Y. Jeong, Bioconjugate Chem. 2001, 12, 932.
32. F. C. MacLaughlin, R. J. Mumper, J. Wang, J. M. Tagliaferri, I. Gill, M. Hinchcliffe, A. P. Rolland, J. Controlled Release 1998, 56, 259.
33. S. K. Sahoo, J. Panyam, S. Prabha, V. Labhasetwar, J. Controlled Release 2002, 82, 105.
34. A. M. Torche, P. Le Corre, E. Albina, A. Jestin, R. Le Verge, J. Drug Targeting 2000, 7, 343.
35. S. Blau, T. T. Jubeh, S. M. Haupt, A. Rubinstein, Crit. Rev. Ther. Drug Carrier Syst. 2000, 17, 425.
36. J. Panyam, W. Z. Zhou, S. Prabha, S. K. Sahoo, V. Labhasetwar, FASEB J. 2002, 16, 1217.
37. A. Catizone, L. Medolago Albani, F. Reola, T. Alescio, Cell. Mol. Biol. 1993, 39, 155.
38. A. Rupper, J. Cardelli, Biochim. Biophys. Acta, Gen. Subj. 2001, 1525, 205.
39. B. D. Chithrani, W. C. Chan, Nano Lett. 2007, 7, 1542.
40. T. Mosmann, J. Immunol. Methods. 1983, 65, 55.
41. Y. Mo, L. Y. Lim, J. Controlled Release 2005, 107, 30.
42. N. Mondal, K. K. Halder, M. M. Kamila, Int. J. Pharm. 2010, 397, 194.
43. D. L. Morse, H. Gray, C. M. Payne, R. J. Gillies, Mol. Cancer Ther. 2005, 4, 1495.
44. S. A. Susin, E. Daugas, L. Ravagnan, K. Samejima, N. Zamzami, M. Loeffler, P. Costantini, K. F. Ferri, T. Irinopoulou, M. C. Prevost, G. Brothers, T. W. Mak, J. Peninger, W. C. Earnshaw, G. Kroemer, J. Exp. Med. 2000, 192, 571.
45. S. Auriola, J. Frith, M. J. Rogers, A. Koivuniemi, J. Monkkonen, J. Chromatogr., B: Biomed. Sci. Appl. 1997, 704, 187.
46. H. L. Benford, J. C. Frith, S. Auriola, J. Monkkonen, M. J. Rogers, Mol. Pharmacol. 1999, 56, 131.
47. H. Monkkonen, S. Auriola, P. Lehenkari, M. Kellinsalmi, I. E. Hassinen, J. Vepsalainen, J. Monkkonen, Br. J. Pharmacol. 2006, 147, 437.
48. J. Williams, R. Lansdown, R. Sweitzer, M. Romanowski, R. LaBell, R. Ramaswami, E. Unger, J. Controlled Release 2003, 91, 167.
49. H. Yoshizawa, S. Nishino, K. Shiomori, S. Natsugoe, T. Aiko, Y. Kitamura, Int. J. Pharm. 2005, 296, 112.
50. P. Ebrahimnejad, R. Dinarvand, M. R. Jafari, S. A. Tabasi, F. Atyabi, Int. J. Pharm. 2011, 406, 122.
51. J. Park, P. M. Fong, J. Lu, K. S. Russell, C. J. Booth, W. M. Saltzman, T. M. Fahmy, Nanomedicine: NBM. 2009, 5, 410.
52. S. Stolnik, C. R. Heald, J. Neal, M. C. Garnett, S. S. Davis, L. Illum, S. C. Purkis, R. J. Barlow, P. R. Gellert, J. Drug Targeting 2001, 9, 361.
53. M. Snehalatha, K. Venugopal, R. N. Saha, A. K. Babbar, R. K. Sharma, Drug Delivery 2008, 15, 277.
54. T. Chen, J. Berenson, R. Vescio, R. Swift, A. Gilchick, S. Goodin, P. LoRusso, P. Ma, C. Ravera, F. Deckert, H. Schran, J. Seaman, A. Skerjanec, J. Clin. Pharmacol. 2002, 42, 1228.
55. J. E. Shea, S. C. Miller, Adv. Drug Delivery Rev. 2005, 57, 945.